{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T15:23:44Z","timestamp":1774538624464,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd009258.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T00:00:00Z","timestamp":1531267200000}}],"reference-count":42,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009258.pub3","type":"journal-article","created":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T19:11:54Z","timestamp":1531336314000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Clobazam monotherapy for focal or generalized seizures"],"prefix":"10.1002","volume":"2018","author":[{"given":"Ravindra","family":"Arya","sequence":"first","affiliation":[{"name":"Cincinnati Children's Hospital Medical Center; Comprehensive Epilepsy Center, Division of Neurology; E4-145, MLC 2015, 3333 Burnet Avenue Cincinnati Ohio USA 45229"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisha","family":"Giridharan","sequence":"additional","affiliation":[{"name":"University of Cincinnati; Cincinnati USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidhu","family":"Anand","sequence":"additional","affiliation":[{"name":"University of Minnesota; Department of Medicine; 420 Delaware Street SE Mayo Mail Code 195 Minneapolis MN USA 55455"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushil K","family":"Garg","sequence":"additional","affiliation":[{"name":"Mayo Clinic College of Medicine; Division of Gastroenterology and Hepatology; Rochester MN USA 55901"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,7,11]]},"reference":[{"issue":"11","key":"10.1002\/14651858.CD009258.pub3-BIB0001|cit1","first-page":"581","article-title":"A prospective, open, controlled and randomised study of clobazam versus carbamazepine in patients with frequent episodes of Rolandic epilepsy","volume":"49","author":"Andrade","year":"2009","journal-title":"Revista de Neurologia"},{"issue":"9","key":"10.1002\/14651858.CD009258.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/j.1528-1157.1998.tb01444.x","article-title":"Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy","volume":"39","author":"Canadian Study Group for Childhood Epilepsy","year":"1998","journal-title":"Epilepsia"},{"issue":"2","key":"10.1002\/14651858.CD009258.pub3-BIB0003|cit3","first-page":"157","article-title":"Safety and efficacy of clobazam versus phenytoin-sodium in the antiepileptic drug treatment of solitary cysticercus granulomas","volume":"54","author":"Kaushal","year":"2006","journal-title":"Neurology India"},{"issue":"1","key":"10.1002\/14651858.CD009258.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1055\/s-0035-1557232","article-title":"Intermittent clobazam in febrile seizures: an Indian experience","volume":"3","author":"Bajaj","year":"2005","journal-title":"Journal of Pediatric Neurology"},{"issue":"2-3","key":"10.1002\/14651858.CD009258.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0920-1211(98)00088-6","article-title":"The cognitive and behavioural effects of clobazam and standard monotherapy are comparable; Canadian Study Group for Childhood Epilepsy","volume":"33","author":"Bawden","year":"1999","journal-title":"Epilepsy Research"},{"issue":"8289","key":"10.1002\/14651858.CD009258.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0140-6736(82)91691-9","article-title":"Clobazam in catamenial epilepsy. A model for evaluating anticonvulsants","volume":"2","author":"Feely","year":"1982","journal-title":"Lancet"},{"issue":"11","key":"10.1002\/14651858.CD009258.pub3-BIB0007|cit7","first-page":"358","article-title":"Catamenial epilepsy as a model for testing a new anticonvulsant (clobazam)","volume":"151","author":"Feely","year":"1982","journal-title":"Irish Journal of Medical Science"},{"issue":"2","key":"10.1002\/14651858.CD009258.pub3-BIB0008|cit8","first-page":"273P","article-title":"Clobazam in the treatment of catamenial epilepsy","volume":"13","author":"Feely","year":"1982","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"12","key":"10.1002\/14651858.CD009258.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1136\/jnnp.47.12.1279","article-title":"Intermittent clobazam for catamenial epilepsy: tolerance avoided","volume":"47","author":"Feely","year":"1984","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD009258.pub3-BIB0010|cit10","first-page":"401","article-title":"Clobazam in refractory epilepsies of children","volume":"55","author":"Figueroa","year":"1984","journal-title":"Revista Chilena de Pediatria"},{"issue":"1","key":"10.1002\/14651858.CD009258.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s12098-010-0220-0","article-title":"Diazepam versus clobazam for intermittent prophylaxis of febrile seizures","volume":"78","author":"Khosroshahi","year":"2011","journal-title":"Indian Journal of Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD009258.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1528-1157.1987.tb03678.x","article-title":"Clobazam in therapy-resistant patients with partial epilepsy: a double-blind placebo-controlled crossover study","volume":"28","author":"Koeppen","year":"1987","journal-title":"Epilepsia"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD009258.pub3-BIB0013|cit13","first-page":"240","article-title":"Intermittent oral prophylaxis in preventing recurrent febrile seizures, diazepam versus clobazam: a randomised study in\u00a0south Indian rural children","volume":"46","author":"Ramachandran Nair","year":"2005","journal-title":"Epilepsia"},{"issue":"1","key":"10.1002\/14651858.CD009258.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF02760577","article-title":"Intermittent clobazam therapy in febrile seizures","volume":"72","author":"Rose","year":"2005","journal-title":"Indian Journal of Pediatrics"},{"key":"10.1002\/14651858.CD009258.pub3-BIB0015|cit15","first-page":"177","article-title":"Clinical experience with clobazam: a new 1,5 benzodiazepine in the treatment of refractory epilepsy","volume":"21","author":"Vajda","year":"1985","journal-title":"Clinical and Experimental Neurology"},{"issue":"3","key":"10.1002\/14651858.CD009258.pub3-BIB0016|cit16","first-page":"229","article-title":"The clinical efficacy of nh-15 (clobazam) for the treatment refractory epilepsy by the double-blind comparative study with inactive placebo","volume":"174","author":"Yagi","year":"1995","journal-title":"Igakunoayumi"},{"issue":"2","key":"10.1002\/14651858.CD009258.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3805\/jjes.15.110","article-title":"Single blind comparative study of clobazam (NH-15) with clonazepam in intractable childhood epilepsies","volume":"15","author":"Yamatogi","year":"1997","journal-title":"Journal of the Japan Epilepsy Society"},{"key":"10.1002\/14651858.CD009258.pub3-BIB0018|cit18","first-page":"45","article-title":"Incidence and Prevalence","volume-title":"Epilepsy. A Comprehensive Textbook","volume":"1","author":"Banerjee","year":"2008"},{"issue":"6","key":"10.1002\/14651858.CD009258.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0895-4356(97)00049-8","article-title":"The results of direct and indirect treatment comparisons in meta- analysis of randomised controlled trials","volume":"50","author":"Bucher","year":"1997","journal-title":"Journal of Clinical Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD009258.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1528-1157.1991.tb04670.x","article-title":"Clobazam in treatment of refractory epilepsy: the Canadian experience. A retrospective study","volume":"32","author":"Canadian Clobazam Cooperative Group","year":"1991","journal-title":"Epilepsia"},{"issue":"7","key":"10.1002\/14651858.CD009258.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1528-1157.1998.tb01167.x","article-title":"Considerations on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsy","volume":"39","author":"The ILAE Commission on Antiepileptic Drugs","year":"1998","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD009258.pub3-BIB0022|cit22","unstructured":"Deeks JJ Higgins JPT Altman DG (editors) Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"3","key":"10.1002\/14651858.CD009258.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD009258.pub3-BIB0024|cit24","first-page":"1","article-title":"Introduction: What is Epilepsy?","volume-title":"Epilepsy. A Comprehensive Textbook","volume":"1","author":"Engel","year":"2008"},{"issue":"4","key":"10.1002\/14651858.CD009258.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.0013-9580.2005.66104.x","article-title":"Epileptic seizures and epilepsy. Definitions proposed by the International League against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)","volume":"46","author":"Fisher","year":"2005","journal-title":"Epilepsia"},{"issue":"7","key":"10.1002\/14651858.CD009258.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1528-1167.2006.00585.x","article-title":"ILAE Treatment Guidelines: Evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes","volume":"47","author":"Glauser","year":"2006","journal-title":"Epilepsia"},{"issue":"3","key":"10.1002\/14651858.CD009258.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/epi.12074","article-title":"Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes","volume":"54","author":"Glauser","year":"2013","journal-title":"Epilepsia"},{"issue":"7414","key":"10.1002\/14651858.CD009258.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009258.pub3-BIB0029|cit29","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD009258.pub3-BIB0030|cit30","unstructured":"Higgins JPT Deeks JJ Altman DG (editors) Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD009258.pub3-BIB0031|cit31","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD009258.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1471-4159.1987.tb03407.x","article-title":"Diazepam increases aminobutyric acid in human cerebrospinal fluid","volume":"49","author":"L\u00f6scher","year":"1987","journal-title":"Journal of Neurochemistry"},{"key":"10.1002\/14651858.CD009258.pub3-BIB0033|cit33","first-page":"179","article-title":"Benzodiazepines. Mechanism of Action","volume-title":"Antiepileptic Drugs","author":"Macdonald","year":"2002"},{"key":"10.1002\/14651858.CD009258.pub3-BIB0034|cit34","volume-title":"Global comparative assessment in the Health Sector; Disease Burden, Expenditures, and Intervention Packages","author":"Murray","year":"1994"},{"key":"10.1002\/14651858.CD009258.pub3-BIB0035|cit35","first-page":"374","article-title":"Antiseizure Drugs","volume-title":"Basic and Clinical Pharmacology","author":"Porter","year":"2007"},{"key":"10.1002\/14651858.CD009258.pub3-BIB0036|cit36","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"1","key":"10.1002\/14651858.CD009258.pub3-BIB0037|cit37","first-page":"1","article-title":"The neurobiology of antiepileptic drugs","volume":"5","author":"Rogawski","year":"2004","journal-title":"Nature Reviews Neuroscience"},{"issue":"8","key":"10.1002\/14651858.CD009258.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/archneur.1986.00520080064023","article-title":"Clobazam for refractory focal epilepsy. A controlled trial","volume":"43","author":"Schmidt","year":"1986","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD009258.pub3-BIB0039|cit39","first-page":"1531","article-title":"Benzodiazepines","volume-title":"Epilepsy. A Comprehensive Textbook","volume":"2","author":"Schmidt","year":"2008"},{"key":"10.1002\/14651858.CD009258.pub3-BIB0040|cit40","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JPT Deeks JJ Glasziou P Chaper 12: Interpreting results and drawing conclusions. In Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated September 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"8","key":"10.1002\/14651858.CD009258.pub3-BIB0041|cit41","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009258","article-title":"Clobazam monotherapy for partial onset or generalized onset seizures","author":"Arya","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD009258.pub3-BIB0042|cit42","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009258.pub2","article-title":"Clobazam monotherapy for partial-onset or generalized-onset seizures","author":"Arya","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD009258.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T08:32:41Z","timestamp":1675845161000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009258.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Epilepsy Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,7,11]]},"references-count":42,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009258.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,11]]}}}